Drug maker Amgen reported "encouraging results" from its Phase II trial of the experimental cancer drug AMG-706, which treats a type of gastrointestinal cancer...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 26 biweekly issues
  • Subscriber-only digital content for prime stories
  • Book of Lists — the most comprehensive business resource in the Valley region
Yours for only $49